MetLife, Inc. $MET Shares Sold by Cwm LLC

Key Points

• Cwm LLC trimmed its stake in MetLife by 29.6% in Q4, selling 16,922 shares and leaving 40,298 shares valued at about $3.18 million.
• Several analysts cut price targets recently (Barclays, Wells Fargo, Morgan Stanley), but the consensus remains a "Moderate Buy" with an average price target of $93.38.
• MetLife reported an EPS beat of $2.49 vs. $2.34 and revenue up 27.6% to $52.44 billion; the stock traded around $76.07 with a market cap of $49.6 billion and a trailing P/E of 16.19.

Cwm LLC trimmed its stake in MetLife, Inc. (NYSE:MET - Free Report) by 29.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 40,298 shares of the financial services provider's stock after selling 16,922 shares during the quarter. Cwm LLC's holdings in MetLife were worth $3,181,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the stock. Brighton Jones LLC boosted its holdings in shares of MetLife by 9.0% in the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock valued at $347,000 after purchasing an additional 351 shares during the last quarter. Caxton Associates LLP acquired a new stake in shares of MetLife during the 1st quarter worth $307,000. Empowered Funds LLC raised its position in shares of MetLife by 187.6% in the 1st quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider's stock worth $2,680,000 after buying an additional 21,771 shares during the period. Sivia Capital Partners LLC purchased a new position in shares of MetLife in the 2nd quarter worth $404,000. Finally, Jump Financial LLC acquired a new position in MetLife in the second quarter valued at $444,000. Hedge funds and other institutional investors own 94.99% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on MET shares. Weiss Ratings lowered MetLife from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, March 9th. Evercore set a $96.00 price objective on MetLife in a research note on Thursday, April 9th. Barclays decreased their target price on MetLife from $92.00 to $89.00 and set an "overweight" rating for the company in a report on Wednesday, April 8th. Wells Fargo & Company cut their price target on shares of MetLife from $93.00 to $90.00 and set an "overweight" rating on the stock in a report on Friday, April 10th. Finally, Morgan Stanley reduced their price target on shares of MetLife from $101.00 to $93.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, MetLife presently has an average rating of "Moderate Buy" and a consensus price target of $93.38.

MetLife Trading Down 1.2%

NYSE:MET opened at $76.07 on Friday. The business's 50-day moving average is $73.09 and its two-hundred day moving average is $76.71. The firm has a market capitalization of $49.60 billion, a PE ratio of 16.19, a price-to-earnings-growth ratio of 0.68 and a beta of 0.74. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $83.85. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, topping the consensus estimate of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The company had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter in the prior year, the business earned $2.08 earnings per share. The company's revenue was up 27.6% compared to the same quarter last year. Research analysts predict that MetLife, Inc. will post 9.85 earnings per share for the current fiscal year.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.